Cancer cells have the unique ability to bypass the Hayflick Limit, allowing them to divide indefinitely. Understanding how cancer cells achieve this can provide insights into potential therapeutic targets. Unlike normal cells, cancer cells often activate telomerase or alternative lengthening of telomeres (ALT) mechanisms to maintain their telomeres and avoid senescence.
